HOXA9 methylation is not associated with survival in Brazilian patients with lung adenocarcinoma.

MLA

Vicente, Anna Luiza Silva Almeida, et al. “HOXA9 Methylation Is Not Associated with Survival in Brazilian Patients with Lung Adenocarcinoma.” Clinical Epigenetics, vol. 17, no. 1, Feb. 2025, p. 25. EBSCOhost, https://doi.org/10.1186/s13148-025-01831-1.

APA

Vicente, A. L. S. A., de Souza Santos, F. A., Hirai, W. Y., Lissa, D., de Oliveira Cavagna, R., da Silva, A. L. V., Dos Reis, M. B., da Silva, E. C. A., da Silva, F. A. F., Mourão, J. D., De Marchi, P., de Carvalho, A. C., Leal, L. F., & Reis, R. M. (2025). HOXA9 methylation is not associated with survival in Brazilian patients with lung adenocarcinoma. Clinical Epigenetics, 17(1), 25. https://doi.org/10.1186/s13148-025-01831-1

Chicago

Vicente, Anna Luiza Silva Almeida, Fabiana Aparecida de Souza Santos, Welinton Yoshio Hirai, Delphine Lissa, Rodrigo de Oliveira Cavagna, Aline Larissa Virginio da Silva, Mariana Bisarro Dos Reis, et al. 2025. “HOXA9 Methylation Is Not Associated with Survival in Brazilian Patients with Lung Adenocarcinoma.” Clinical Epigenetics 17 (1): 25. doi:10.1186/s13148-025-01831-1.